Dermatology Consulting Services

1. Bausch Health US, LLC $676,011 29 payments
2. Taro Pharmaceuticals USA, Inc. $211,163 31 payments
3. Amgen Inc. $174,563 13 payments
4. Eli Lilly and Company $129,292 3 payments
5. E.R. Squibb & Sons, L.L.C. $103,368 5 payments
6. LEO Pharma AS $67,279 14 payments
7. Celgene Corporation $40,671 3 payments
8. Dr.Reddy's Laboratories,Inc. $12,516 7 payments
9. Vanda Pharmaceuticals Inc. $9,638 3 payments
10. VYNE Pharmaceuticals Inc. $4,503 6 payments

1. Single Center Post-Marketing Evaluation of the Long Term Efficacy and Tolerability of Clindamycin Phosphate 1.2% Adapalene 0.15 % Benzoyle Peroxide 3.1 % Gel (Cabtreo) for Acne $155,985 3 payments
2. Part II: Single-Center Post- Marketing Evaluation of the Long Term Efficacy and Tolerability of Clindamycin Phosphate 1.2%/ Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel (Cabtreo)for Acne $142,500 1 payment
3. A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-To-Severe Plaque Psoriasis $123,810 2 payments
4. Efficacy Safety Study of Apremilast in Subjects With Moderate to Severe Genital Psoriasis(PSOR-025) $110,763 4 payments
5. A Multi-Center, Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase 3 Study with an Induction Period Followed by a Randomized Maintenance Period to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis $68,085 1 payment
6. Dose-Ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 MG/G Compared to Delgocitinib Cream Vehicle Over An 8-Week Treatment Period in Adult Subjects With Atopic Dermatitis. $66,966 11 payments
7. BTCG 1808 $56,395 7 payments
8. A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of Idp-126 Gel to Epiduo? Forte Gel (0.3% Adapalene/2.5% Bpo), in the Treatment of Acne Vulgaris $54,888 6 payments
9. Efficacy Safety Study of Apremilast in Subjects With Moderate to Severe Genital Psoriasis (PSOR-025) $51,725 2 payments
10. A Demonstration of the Hair and Scalp Benefits of 0.045% Tazarotene/0.01% Halobetasol Lotion in Scalp Psoriasis $50,500 2 payments

1. Professional salary support $172,710 23 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.